Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $8,000 | 3 | 81.6% |
| Unspecified | $1,769 | 1 | 18.0% |
| Food and Beverage | $34.87 | 1 | 0.4% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| USWM, LLC | $7,000 | 2 | $0 (2023) |
| Novartis Pharma AG | $1,769 | 1 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $1,000 | 1 | $0 (2019) |
| Shire North American Group Inc | $34.87 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,769 | 1 | Novartis Pharma AG ($1,769) |
| 2023 | $7,000 | 2 | USWM, LLC ($7,000) |
| 2019 | $1,000 | 1 | Merck Sharp & Dohme Corporation ($1,000) |
| 2017 | $34.87 | 1 | Shire North American Group Inc ($34.87) |
All Payment Transactions
5 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/08/2024 | Novartis Pharma AG | KISQALI (Drug) | — | Cash or cash equivalent | $1,768.75 | Research |
| Study: CLEE011Q12101 • Category: ONCOLOGY | ||||||
| 09/15/2023 | USWM, LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 09/15/2023 | USWM, LLC | — | Consulting Fee | Cash or cash equivalent | $3,500.00 | General |
| 01/15/2019 | Merck Sharp & Dohme Corporation | MK-4280 (Biological) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2017 | Shire North American Group Inc | ONCASPAR (Biological) | Food and Beverage | In-kind items and services | $34.87 | General |
| Category: ONCOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| CLEE011Q12101 | Novartis Pharma AG | $1,769 | 1 |
About Dr. Navin Pinto, M.D
Dr. Navin Pinto, M.D is a Pediatric Hematology-Oncology healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1538326632.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Navin Pinto, M.D has received a total of $9,804 in payments from pharmaceutical and medical device companies, with $1,769 received in 2024. These payments were reported across 5 transactions from 4 companies. The most common payment nature is "Consulting Fee" ($8,000).
Practice Information
- Specialty Pediatric Hematology-Oncology
- Other Specialties Pediatric Hematology-Oncology
- Location Seattle, WA
- Active Since 05/18/2008
- Last Updated 08/10/2023
- Taxonomy Code 2080P0207X
- Entity Type Individual
- NPI Number 1538326632
Products in Payments
- KISQALI (Drug) $1,769
- MK-4280 (Biological) $1,000
- ONCASPAR (Biological) $34.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Hematology-Oncology Doctors in Seattle
Dr. Rachel Rau, Md, MD
Pediatric Hematology-Oncology — Payments: $68,797
Dr. Paul Carpenter
Pediatric Hematology-Oncology — Payments: $35,523
Douglas Hawkins
Pediatric Hematology-Oncology — Payments: $31,806
Rebecca Gardner, Md, MD
Pediatric Hematology-Oncology — Payments: $20,740
Soheil Meshinchi, Md,Phd, MD,PHD
Pediatric Hematology-Oncology — Payments: $17,418
Dr. Michael Bender, M.d. , Phd, M.D. , PHD
Pediatric Hematology-Oncology — Payments: $7,865